Showing results (21-30 of 117) with videos related to

Sort By:
Pageof 12
The Journal of Urology|June 21, 2011
Optimization of nonmuscle invasive bladder cancer recurrence detection using a urine based FGFR3 mutation assayTahlita C M Zuiverloon, Stephen S Tjin, Martijn Busstra, et al.
Nature Reviews. Urology|September 23, 2015
Targeted therapies in bladder cancer: an overview of in vivo researchKim E M van Kessel, Tahlita C M Zuiverloon, Arnout R Alberts, et al.
European Urology|October 24, 2008
Expression of the endothelin axis in noninvasive and superficially invasive bladder cancer: relation to clinicopathologic and molecular prognostic parametersElke Eltze, Peter J Wild, Christian Wülfing, et al.
Research and Reports in Urology|November 8, 2013
A noninvasive multi-analyte diagnostic assay: combining protein and DNA markers to stratify bladder cancer patientsCecilia A Fernandez, John M Millholland, Ellen C Zwarthoff, et al.
European Urology|October 18, 2011
Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic reviewTahlita C M Zuiverloon, Annemieke J M Nieuweboer, Hedvig Vékony, et al.
Virchows Archiv : an International Journal of Pathology|July 11, 2012
Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?Willemien Beukers, Titia Meijer, Cornelis J Vissers, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 23, 2007
FGFR3 mutations in seborrheic keratoses are already present in flat lesions and associated with age and localizationChristian Hafner, Arndt Hartmann, Johanna M M van Oers, et al.
Plos One|January 26, 2010
Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genesIrene Lurkin, Robert Stoehr, Carolyn D Hurst, et al.
Scientific Reports|May 23, 2019
Urinary peptide panel for prognostic assessment of bladder cancer relapseMagdalena Krochmal, Kim E M van Kessel, Ellen C Zwarthoff, et al.
Plos One|October 22, 2013
The use of molecular analyses in voided urine for the assessment of patients with hematuriaWillemien Beukers, Raju Kandimalla, Diandra van Houwelingen, et al.
Pageof 12